Politics Rachel Cohrs STAT Plus: New Senate proposal to lower insulin prices would let drugmakers lock in their current profits
Pharmalot Ed Silverman STAT Plus: Under pressure, Trump administration looks to cap insulin costs with a Medicare program
Politics Lev Facher and Nicholas Florko STAT Plus: Sensing an advantage, Democrats dare Trump to talk drug prices during State of the Union
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Opioid judge refuses to disqualify himself; Biocon to lower insulin price in some countries
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue
Pharmalot Ed Silverman STAT Plus: How much? Medicare Part D spending on insulin has been skyrocketing
Pharmalot Ed Silverman STAT Plus: Insulin costs for U.S. patients nearly doubled from 2012 through 2016, but usage was flat
Business Megan Thielking STAT Plus: Sound advice: Company aims to make drug packaging easy — and helpful